Deutsche Bank has been appointed as depositary bank for the sponsored Level I American Depositary Receipt (ADR) program of H. Lundbeck A/S (Lundbeck), an international pharmaceutical company focused on brain disorders.
Lundbeck employs 6,000 people in 57 countries, and its products are registered in more than 100 countries. The Denmark-headquartered company generated revenue of approximately DKK16 billion ($2.7 billion) in 2011.
This notable mandate from Lundbeck was awarded to Deutsche Bank based on our strong capabilities in ADR depositary services, leveraging our considerable global network and market knowledge to support the capital strategies of our clients, says Akbar Poonawala, head of Global Equity Services at Deutsche Bank. We will deliver a broad range of customized ADR services to assist Lundbeck with its investor relations and to expand its shareholder base.
(CG)